1. Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
   Kazuomi Ueshima et al, 2020, Liver Cancer CrossRef
2. Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
   Bingran Yu et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
3. A long-term survival case of advanced hepatocellular carcinoma treated with multidisciplinary therapies with progression to hepatic arterial infusion chemotherapy and hepatectomy
   Hiroyuki Suzuki et al, 2020, Kanzo CrossRef
4. Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
   Hideki Iwamoto et al, 2021, Cancers CrossRef
5. Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
   Wei Zhang et al, 2023, Frontiers in Oncology CrossRef
6. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
   Jaejun Lee et al, 2021, Journal of Clinical Medicine CrossRef
7. Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial
   YUICHI GOTO et al, 2021, The Kurume Medical Journal CrossRef
8. Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
   Ching-Tso Chen et al, 2021, International Journal of Molecular Sciences CrossRef